NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I go back to the fact that it takes more extensive deliberations to determine if they are going to stop for efficacy. This initial decision (continuance for safety) gives the DMC (and possibly CRO) breathing room to perhaps follow the path Ou and f3tt3f suggested, which is to wait for the 88th event. This allows more data for any eventual presentation to the FDA.

This may mean our next "glimpse" on anything DCVAX related will be a "shout from the rooftops" at ASCO in May on DCVAX-Direct.

Still, I expect some announcements on Germany (reimbursement?) and DCVAX Direct clinic expansion in the meantime.